UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Management and outcome of isolated atrial septal defects in children

Authors
G Wesley Vick, III, MD
Louis I Bezold, MD
Section Editor
John K Triedman, MD
Deputy Editor
Carrie Armsby, MD, MPH

INTRODUCTION

Congenital defects of the atrial septum are common, accounting for approximately 7 percent of congenital heart disorders [1]. They can occur in several different anatomic portions of the atrial septum, and the location of the defect generally reflects the abnormality of embryogenesis that led to the anomaly (figure 1). An atrial septal defect (ASD) can be isolated or can be associated with other congenital cardiac abnormalities. The sizes of ASDs are variable, and their functional consequences are related to the anatomic location of the defect, its size, the presence or absence of other cardiac anomalies, as well as systolic and diastolic function of the ventricles.

The management and outcomes of children with an isolated ASD will be reviewed here. The classification of ASDs, and the pathophysiology, clinical features, and diagnosis of isolated ASD in children are discussed separately. (See "Classification of atrial septal defects (ASDs), and clinical features and diagnosis of isolated ASDs in children".)

GENERAL CONSIDERATIONS

The following issues need to be considered in the management of an isolated atrial septal defect (ASD) in children:

Likelihood of spontaneous closure

Size of a persistent ASD and degree of shunting across the defect

                        

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Wed Jan 27 00:00:00 GMT 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Feldt RH, Avasthey P, Yoshimasu F, et al. Incidence of congenital heart disease in children born to residents of Olmsted County, Minnesota, 1950-1969. Mayo Clin Proc 1971; 46:794.
  2. Radzik D, Davignon A, van Doesburg N, et al. Predictive factors for spontaneous closure of atrial septal defects diagnosed in the first 3 months of life. J Am Coll Cardiol 1993; 22:851.
  3. Hanslik A, Pospisil U, Salzer-Muhar U, et al. Predictors of spontaneous closure of isolated secundum atrial septal defect in children: a longitudinal study. Pediatrics 2006; 118:1560.
  4. Helgason H, Jonsdottir G. Spontaneous closure of atrial septal defects. Pediatr Cardiol 1999; 20:195.
  5. Windecker S, Meier B. Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale and cryptogenic stroke: to close or not to close? Closure: what else! Circulation 2008; 118:1989.
  6. Messé SR, Kasner SE. Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale in cryptogenic stroke: not to close. Circulation 2008; 118:1999.
  7. McMahon CJ, Feltes TF, Fraley JK, et al. Natural history of growth of secundum atrial septal defects and implications for transcatheter closure. Heart 2002; 87:256.
  8. Vick GW III. Defects of the atrial septum Including atrioventricular septal defects. In: Science and Practice of Pediatric Cardiology, 2nd ed, Garson A Jr, Bricker JT, Fisher DJ, Neish SR (Eds), Williams & Wilkins, Baltimore 1998. p.1141.
  9. Attie F, Rosas M, Granados N, et al. Surgical treatment for secundum atrial septal defects in patients >40 years old. A randomized clinical trial. J Am Coll Cardiol 2001; 38:2035.
  10. Driscoll D, Allen HD, Atkins DL, et al. Guidelines for evaluation and management of common congenital cardiac problems in infants, children, and adolescents. A statement for healthcare professionals from the Committee on Congenital Cardiac Defects of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1994; 90:2180.
  11. Gatzoulis MA, Freeman MA, Siu SC, et al. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med 1999; 340:839.
  12. Bartakian S, Fagan TE, Schaffer MS, Darst JR. Device closure of secundum atrial septal defects in children <15 kg: complication rates and indications for referral. JACC Cardiovasc Interv 2012; 5:1178.
  13. Hopkins RA, Bert AA, Buchholz B, et al. Surgical patch closure of atrial septal defects. Ann Thorac Surg 2004; 77:2144.
  14. Jones DA, Radford DJ, Pohlner PG. Outcome following surgical closure of secundum atrial septal defect. J Paediatr Child Health 2001; 37:274.
  15. Geva T, Martins JD, Wald RM. Atrial septal defects. Lancet 2014; 383:1921.
  16. Heching HJ, Bacha EA, Liberman L. Post-pericardiotomy syndrome in pediatric patients following surgical closure of secundum atrial septal defects: incidence and risk factors. Pediatr Cardiol 2015; 36:498.
  17. Murphy JG, Gersh BJ, McGoon MD, et al. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med 1990; 323:1645.
  18. Roos-Hesselink JW, Meijboom FJ, Spitaels SE, et al. Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age. A prospective follow-up study of 21-33 years. Eur Heart J 2003; 24:190.
  19. Schwetz BA. From the Food and Drug Administration. JAMA 2002; 287:578.
  20. Delaney JW, Chan KC, Rhodes JF Jr. The design and deployment of the HELEX septal occluder. Congenit Heart Dis 2006; 1:202.
  21. Latson LA, Jones TK, Jacobson J, et al. Analysis of factors related to successful transcatheter closure of secundum atrial septal defects using the HELEX septal occluder. Am Heart J 2006; 151:1129.e7.
  22. Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation 2003; 107:5.
  23. Cao Q, Radtke W, Berger F, et al. Transcatheter closure of multiple atrial septal defects. Initial results and value of two- and three-dimensional transoesophageal echocardiography. Eur Heart J 2000; 21:941.
  24. Ewert P, Berger F, Daehnert I, et al. Transcatheter closure of atrial septal defects without fluoroscopy: feasibility of a new method. Circulation 2000; 101:847.
  25. Earing MG, Cabalka AK, Seward JB, et al. Intracardiac echocardiographic guidance during transcatheter device closure of atrial septal defect and patent foramen ovale. Mayo Clin Proc 2004; 79:24.
  26. Bartel T, Konorza T, Arjumand J, et al. Intracardiac echocardiography is superior to conventional monitoring for guiding device closure of interatrial communications. Circulation 2003; 107:795.
  27. Zanchetta M, Onorato E, Rigatelli G, et al. Intracardiac echocardiography-guided transcatheter closure of secundum atrial septal defect: a new efficient device selection method. J Am Coll Cardiol 2003; 42:1677.
  28. Mullen MJ, Dias BF, Walker F, et al. Intracardiac echocardiography guided device closure of atrial septal defects. J Am Coll Cardiol 2003; 41:285.
  29. Boccalandro F, Baptista E, Muench A, et al. Comparison of intracardiac echocardiography versus transesophageal echocardiography guidance for percutaneous transcatheter closure of atrial septal defect. Am J Cardiol 2004; 93:437.
  30. Chan KC, Godman MJ, Walsh K, et al. Transcatheter closure of atrial septal defect and interatrial communications with a new self expanding nitinol double disc device (Amplatzer septal occluder): multicentre UK experience. Heart 1999; 82:300.
  31. Du ZD, Hijazi ZM, Kleinman CS, et al. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol 2002; 39:1836.
  32. Chessa M, Carminati M, Butera G, et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 2002; 39:1061.
  33. Berdat PA, Chatterjee T, Pfammatter JP, et al. Surgical management of complications after transcatheter closure of an atrial septal defect or patent foramen ovale. J Thorac Cardiovasc Surg 2000; 120:1034.
  34. El-Said H, Hegde S, Foerster S, et al. Device therapy for atrial septal defects in a multicenter cohort: acute outcomes and adverse events. Catheter Cardiovasc Interv 2015; 85:227.
  35. Divekar A, Gaamangwe T, Shaikh N, et al. Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. J Am Coll Cardiol 2005; 45:1213.
  36. Tchantchaleishvili V, Melvin AL, Ling FS, Knight PA. Late erosion of Amplatzer septal occluder device resulting in cardiac tamponade. Interact Cardiovasc Thorac Surg 2014; 19:1074.
  37. Kister T, Dähnert I, Lurz P. Fatal Erosion Atrial Septal Defect Device. Catheter Cardiovasc Interv 2016; 87:951.
  38. McElhinney DB. Patent foramen ovale closure: let's keep the heart in mind. Circulation 2009; 119:2967.
  39. Berger F, Vogel M, Alexi-Meskishvili V, Lange PE. Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects. J Thorac Cardiovasc Surg 1999; 118:674.
  40. Silverstein MD, Qin H, Mercer SQ, et al. Risk factors for 30-day hospital readmission in patients ≥65 years of age. Proc (Bayl Univ Med Cent) 2008; 21:363.
  41. Masura J, Gavora P, Podnar T. Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders. J Am Coll Cardiol 2005; 45:505.
  42. Diab KA, Cao QL, Bacha EA, Hijazi ZM. Device closure of atrial septal defects with the Amplatzer septal occluder: safety and outcome in infants. J Thorac Cardiovasc Surg 2007; 134:960.
  43. Bishnoi RN, Everett AD, Ringel RE, et al. Device closure of secundum atrial septal defects in infants weighing less than 8 kg. Pediatr Cardiol 2014; 35:1124.
  44. Pedra CA, Pihkala J, Lee KJ, et al. Transcatheter closure of atrial septal defects using the Cardio-Seal implant. Heart 2000; 84:320.
  45. Smith BG, Wilson N, Richens T, Knight WB. Midterm follow-up of percutaneous closure of secundum atrial septal defect with Helex Septal Occluder. J Interv Cardiol 2008; 21:363.
  46. Kotowycz MA, Therrien J, Ionescu-Ittu R, et al. Long-term outcomes after surgical versus transcatheter closure of atrial septal defects in adults. JACC Cardiovasc Interv 2013; 6:497.
  47. Castaldi B, Vida VL, Argiolas A, et al. Late Electrical and Mechanical Remodeling After Atrial Septal Defect Closure in Children: Surgical Versus Percutaneous Approach. Ann Thorac Surg 2015; 100:181.
  48. Van Hare GF, Ackerman MJ, Evangelista JA, et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation 2015; 132:e281.